Ftse Mib
34.716,46
0,65%
DAX
18.629,98
0,79%
S&P 500
5.277,51
0,80%
NASDAQ
16.735,02
-0,01%
Bitcoin
69.052,20
1,92%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ VYNE Therapeutics Inc (VYNE) VYNE Therapeutics Inc (VYNE) Notizie

VYNE

VYNE Therapeutics (VYNE)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:VYNE
DataOraFonteTitoloSimboloCompagnia
09/05/202422:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VYNEVYNE Therapeutics Inc
09/05/202414:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VYNEVYNE Therapeutics Inc
01/03/202423:16Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:VYNEVYNE Therapeutics Inc
01/03/202423:15Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:VYNEVYNE Therapeutics Inc
02/02/202415:42Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:VYNEVYNE Therapeutics Inc
03/01/202423:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYNEVYNE Therapeutics Inc
03/01/202423:01Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VYNEVYNE Therapeutics Inc
24/11/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:VYNEVYNE Therapeutics Inc
22/11/202322:07Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VYNEVYNE Therapeutics Inc
16/11/202322:30Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:VYNEVYNE Therapeutics Inc
13/11/202322:03Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:VYNEVYNE Therapeutics Inc
13/11/202322:01Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:VYNEVYNE Therapeutics Inc
13/11/202321:59Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:VYNEVYNE Therapeutics Inc
02/06/202322:35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VYNEVYNE Therapeutics Inc
11/05/202322:25Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VYNEVYNE Therapeutics Inc
11/05/202322:22Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VYNEVYNE Therapeutics Inc
14/03/202322:14Edgar (US Regulatory)Annual Report (10-k)NASDAQ:VYNEVYNE Therapeutics Inc
10/01/202314:45AllPennyStocks.comBiotech Catches Major Premarket BidNASDAQ:VYNEVYNE Therapeutics Inc
25/11/202220:01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:VYNEVYNE Therapeutics Inc
18/11/202223:01Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:VYNEVYNE Therapeutics Inc
14/11/202222:51Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:VYNEVYNE Therapeutics Inc
11/11/202212:25TipRanksVYNE Therapeutics (VYNE) Gets a Buy from H.C. WainwrightNASDAQ:VYNEVYNE Therapeutics Inc
10/08/202216:10TipRanksAnalysts Offer Insights on Healthcare Companies: VYNE Therapeutics (VYNE) and MiNK Therapeutics (INKT)NASDAQ:VYNEVYNE Therapeutics Inc
28/07/202222:31Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:VYNEVYNE Therapeutics Inc
21/06/202211:06TipRanksLifeSci Capital Thinks VYNE Therapeutics’ Stock is Going to RecoverNASDAQ:VYNEVYNE Therapeutics Inc
19/06/202209:50TipRanksVYNE Therapeutics (VYNE) Gets a Buy Rating from H.C. WainwrightNASDAQ:VYNEVYNE Therapeutics Inc
24/05/202210:15TipRanksAnalysts Offer Insights on Healthcare Companies: VYNE Therapeutics (VYNE) and Nano-X Imaging (NNOX)NASDAQ:VYNEVYNE Therapeutics Inc
20/05/202211:01TipRanksAnalysts Offer Insights on Healthcare Companies: and VYNE Therapeutics (VYNE)NASDAQ:VYNEVYNE Therapeutics Inc
18/05/202212:18TipRanksH.C. Wainwright Thinks VYNE Therapeutics’ Stock is Going to RecoverNASDAQ:VYNEVYNE Therapeutics Inc
12/05/202223:01Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:VYNEVYNE Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:VYNE

La tua Cronologia

NASDAQ
HOLX
Hologic
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network